HERBERT E KAUFMAN
Medical Practice at Watergate Dr, Sarasota, FL
License number
Florida 97549
Issued Date
Dec 7, 2006
Effective Date
Feb 1, 2017
Expiration Date
Jan 31, 2017
Category
Health Care
Type
Medical Doctor
Address
Address
2
35 Watergate Dr APT 404, Sarasota, FL 34236
2020 Gravier St, New Orleans, LA 70112
2020 Gravier St, New Orleans, LA 70112
Phone
(941) 822-2039
Organization information
See more information about HERBERT E KAUFMAN at bizstanding.comHerbert E Kaufman
935 Contento St, Sarasota, FL 34242
Industry:
Ret Misc Homefurnishings
Owner:
Herbert Kaufman (Owner)
Professional information
Editor Investigative Ophthalmology, Nei Advisory Board ,President Arvo At A Rvo
Position:
Consultant at HK Consultation, Editor Investigative Ophthalmology, NEI advisory board ,president ARVO at A RVO
Location:
Sarasota, Florida Area
Industry:
Pharmaceuticals
Work:
HK Consultation
-
Consultant
A RVO
- Sarasota since Jul 1965
-
Editor Investigative Ophthalmology, NEI advisory board ,president ARVO
Interests:
Developed first antiviral drug( IDU)-introduced Viroptic- introduced combined steroid antiviral RX
Introduced Natamycin, timolol, and began topical carbonic anhydrase project - lacriserts
Corneal preservation- M-K medium , Optisol, Developed bandage soft lenses ,co developer peroxide sterilization of soft lenses
Co Developer of Clinical Specular Microscope. First used viscoelastics. Developer Epikeratophakia
Trained 130 corneal fellows
Co developer of Clinical excimer laser
Dr. Herbert E Kaufman, New Orleans LA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
2020 Gravier St STE B, New Orleans 70112
(504) 412-1200 (Phone), (504) 412-1321 (Fax)
(504) 412-1200 (Phone), (504) 412-1321 (Fax)
Certifications:
Ophthalmology, 1962
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese
Education:
Medical School
Harvard Medical School
Massachusetts General Hospital
Natl Inst Hlth
Massachusetts Eye and Ear Infirmary
Harvard Medical School
Massachusetts General Hospital
Natl Inst Hlth
Massachusetts Eye and Ear Infirmary
Use Of Cox-2 Inhibitors To Prevent Recurrences Of Herpesvirus Infections
US Patent:
2003019, Oct 16, 2003
Filed:
Apr 15, 2002
Appl. No.:
10/122666
Inventors:
Herbert Kaufman - New Orleans LA, US
Bryan Gebhardt - New Orleans LA, US
Emily Varnell - New Orleans LA, US
Bryan Gebhardt - New Orleans LA, US
Emily Varnell - New Orleans LA, US
International Classification:
A61K031/415, A61K031/365
US Classification:
514/406000, 514/473000
Abstract:
Selective inhibitors for COX-2 were discovered to prevent the reactivation of viruses that cause latent infections such as herpes simplex virus (HSV-1 and HSV-2). Using mice with a latent infection of HSV, which is subject to reactivation when heat-stressed, a selective COX-2 inhibitor (celecoxib) was shown to significantly suppress viral reactivation in the eye when the inhibitor was administered either by intraperitoneal injection or orally. Acetylsalicylic acid, a nonspecific cyclooxygenase inhibitor, was also found to suppress viral reactivation in this heat-stress mouse model. The COX-2 specific inhibitor, celecoxib, was more effective in preventing viral recurrence than was the nonspecific cyclooxygenase inhibitor aspirin. The use of selective inhibitors of COX-2 to inhibit the recurrence of latent viral infections will be more effective and have fewer side effects than the nonspecific inhibitors. In addition, selective inhibitors of COX-2 can be combined with other known antiviral compounds.
Preparations And Methods For Ameliorating Or Reducing Presbyopia
US Patent:
2010029, Nov 25, 2010
Filed:
May 24, 2010
Appl. No.:
12/785734
Inventors:
Herbert E. KAUFMAN - Sarasota FL, US
International Classification:
A61K 31/498, A61K 31/27, A61P 27/02
US Classification:
514249, 514479
Abstract:
This application relates to the use of one or more parasympathomimetic drugs in combination with one or more alpha agonists to create optically beneficial miosis to, for example, temporarily treat presbyopia. The invention provides a pharmaceutical preparation comprising a therapeutically effective amount of one or more parasympathomimetic drugs or cholinesterase inhibitors, or a pharmaceutically acceptable salt thereof, in combination with one or more alpha agonists or antagonists, or a pharmaceutically acceptable salt thereof. The invention further provides for a method for treating, ameliorating or reducing presbyopia of a patient having an eye, comprising administering to said eye a pharmaceutically effective amount of the ophthalmic preparation.
Eye Treatment Suspension
US Patent:
4923699, May 8, 1990
Filed:
Jun 3, 1988
Appl. No.:
7/201933
Inventors:
Herbert E. Kaufman - New Orleans LA
International Classification:
A61M 3100
US Classification:
424427
Abstract:
An ophthalmic treatment system is provided which includes three-dimensional particles of bioerodible material suspended in a liquid carrier or ointment carrier having a pH acceptable to the eye. The particles are at least 0. 5 mm in greatest dimension and are not greater than 0. 4 mm to 0. 7 mm in smallest dimension when disposed in the ocular environment. The treatment system provides reliable, prolonged continuous treatment without irritating the eye.
Preparations And Methods For Ameliorating Or Reducing Presbyopia
US Patent:
2013024, Sep 19, 2013
Filed:
Apr 26, 2013
Appl. No.:
13/871403
Inventors:
Herbert F. Kaufman - Sarasota FL, US
Assignee:
HEK Development, LLC - Sarasota FL
International Classification:
A61K 31/498, A61K 31/27
US Classification:
514249
Abstract:
This application relates to the use of one or more parasympathomimetic drugs in combination with one or more alpha agonists to create optically beneficial miosis to, for example, temporarily treat presbyopia. The invention provides a pharmaceutical preparation comprising a therapeutically effective amount of one or more parasympathomimetic drugs or cholinesterase inhibitors, or a pharmaceutically acceptable salt thereof, in combination with one or more alpha agonists or antagonists, or a pharmaceutically acceptable salt thereof. The invention further provides for a method for treating, ameliorating or reducing presbyopia of a patient having an eye, comprising administering to said eye a pharmaceutically effective amount of the ophthalmic preparation.
Method, Device, And System For Delivery Of Therapeutic Agents To The Eye
US Patent:
2012025, Oct 4, 2012
Filed:
Jun 12, 2012
Appl. No.:
13/494252
Inventors:
Herbert Edward Kaufman - Sarasota FL, US
International Classification:
A61F 9/00, A61M 35/00
US Classification:
604301
Abstract:
A method, device, and system for easier, consistent, and comfortable delivery of therapeutic agents to the front of the eye.
Method, Device, And System For Delivery Of Therapeutic Agents To The Eye
US Patent:
8216603, Jul 10, 2012
Filed:
May 4, 2007
Appl. No.:
12/226963
Inventors:
Herbert Edward Kaufman - New Orleans LA, US
International Classification:
A61F 2/00
US Classification:
424428, 514912
Abstract:
A method, device, and system for easier, consistent, and comfortable delivery of therapeutic agents to the front of the eye.
Trephine And Method
US Patent:
4763651, Aug 16, 1988
Filed:
Jan 14, 1986
Appl. No.:
6/818737
Inventors:
Herbert E. Kaufman - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61B 1732
US Classification:
128310
Abstract:
A trephine for cutting a groove in the cornea of an eye comprising a fixation member and a shaft having first and second blades mounted thereon. The fixation member includes a bearing, and the shaft is receivable within the bearing. The fixation member can be affixed to the eye, and the shaft, when received in the bearing, is rotatable in the bearing so that the blades can make cuts in the cornea. By making cuts in the cornea which intersect, a segment of the cornea can be removed to provide the groove.
Trephine And Method
US Patent:
4750491, Jun 14, 1988
Filed:
Nov 8, 1984
Appl. No.:
6/670396
Inventors:
Herbert E. Kaufman - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61B 1732
US Classification:
128305
Abstract:
A trephine for cutting a groove in the cornea of an eye comprising a fixation member and first and second shafts having blades mounted thereon. The fixation member includes a bearing, and the shafts are sequentially receivable within the bearing. The fixation member can be affixed to the eye, and the shafts, when received in the bearing, are rotatable in the bearing so that the blades carried by the shafts can make cuts in the cornea. By making cuts in the cornea which intersect, a segment of the cornea can be removed to provide the groove.